Immunodetection of 11 beta-hydroxysteroid dehydrogenase type 2 in human mineralocorticoid target tissues: Evidence for nuclear localization

被引:84
|
作者
Shimojo, M
Ricketts, ML
Petrelli, MD
Moradi, P
Johnson, GD
Bradwell, AR
Hewison, M
Howie, AJ
Stewart, PM
机构
[1] UNIV BIRMINGHAM, QUEEN ELIZABETH HOSP, DEPT MED, BIRMINGHAM B15 2TH, W MIDLANDS, ENGLAND
[2] UNIV BIRMINGHAM, QUEEN ELIZABETH HOSP, DEPT PATHOL, BIRMINGHAM B15 2TH, W MIDLANDS, ENGLAND
关键词
D O I
10.1210/en.138.3.1305
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
11 beta-Hydroxysteroid dehydrogenase (11 beta HSD) is an enzyme complex responsible for the conversion of hormonally active cortisol to inactive cortisone; two isoforms of the enzyme have been cloned and characterized. Clinical observations from patients with the hypertensive syndrome apparent mineralocorticoid excess, recently explained on the basis of mutations in the human 11 beta HSD2 gene, suggest that it is the 11 beta HSD2 isoform that serves a vital role in dictating specificity upon the mineralocorticoid receptor (MR). We have raised a novel antibody in sheep against human 11 beta HSD2 using synthetic multiantigenic peptides and have examined the localization and subcellular distribution of 11 beta HSD2 in mineralocorticoid target tissues. The immunopurified antibody recognized a single band of approximately 44 kDa in placenta, trophoblast, and distal colon. In kidney tissue, two bands of approximately 44 and 48 kDa were consistently observed. No signal was seen in decidua, adrenal, or liver. Immunoperoxidase studies on the mineralocorticoid target tissues, kidney, colon, and parotid gland indicated positive staining in epithelial cells known to express the MR: respectively, renal collecting ducts, surface and crypt colonic epithelial cells, and parotid duct epithelial cells. No staining was seen in these tissues in other sites. The intracellular localization of 11 beta HSD2 in kidney and colon epithelial cells was addressed using confocal laser microscopy. Parallel measurements of 11 beta HSD2 and nuclear propidium iodide fluorescence on sections scanned through an optical section of approximately 0.1 mu m indicated significant 11 beta HSD2 immunofluorescence in the nucleus. In human kidney, colon, and salivary gland, 11 beta HSD2 protects the MR from glucocorticoid excess in an autocrine fashion. Furthermore, within these tissues, 11 beta HSD2, which had been considered to be a microsomal enzyme, is also found in the nucleus, suggesting that the interaction between the MR and aldosterone or cortisol is in part a nuclear event.
引用
收藏
页码:1305 / 1311
页数:7
相关论文
共 50 条
  • [31] 17 beta-hydroxysteroid dehydrogenase activity correlates with the type-2 17 beta-hydroxysteroid dehydrogenase mRNA abundance in human meningioma tumors
    Carsol, JL
    Adamski, J
    Guirou, O
    Gerard, H
    Martin, PM
    deLaunoit, Y
    NEUROENDOCRINOLOGY, 1996, 64 (01) : 70 - 78
  • [32] Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: A molecular analysis of apparent mineralocorticoid excess
    Whorwood, CB
    Stewart, PM
    JOURNAL OF HYPERTENSION, 1996, 14 : S19 - S24
  • [33] HUMAN SKIN AS TARGET FOR ALDOSTERONE - COEXPRESSION OF MINERALOCORTICOID RECEPTORS AND 11-BETA-HYDROXYSTEROID DEHYDROGENASE
    KENOUCH, S
    LOMBES, M
    DELAHAYE, F
    EUGENE, E
    BONVALET, JP
    FARMAN, N
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (05): : 1334 - 1341
  • [34] Expression and regulation of 17 beta-hydroxysteroid dehydrogenase type 1 in steroidogenic cells and estrogen target tissues
    Isomaa, VV
    Peltoketo, EH
    Poutanen, MH
    Vihko, RK
    HORMONAL CARCINOGENESIS II, 1996, : 156 - 166
  • [35] Ontogeny and sexual dimorphic expression of mouse type 2 11 beta-hydroxysteroid dehydrogenase
    Condon, J
    Ricketts, ML
    Whorwood, CB
    Stewart, PM
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1997, 127 (02) : 121 - 128
  • [36] LIQUORICE INDUCED MINERALOCORTICOID EXCESS - 11 BETA-HYDROXYSTEROID DEHYDROGENASE-DEFICIENCY COMES OF AGE
    STEWART, PM
    WALLACE, M
    VALENTINO, R
    BURT, D
    EDWARDS, CRW
    JOURNAL OF HYPERTENSION, 1987, 5 (06) : 768 - 769
  • [37] Molecular analysis of 11 beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess
    White, PC
    Mune, T
    Rogerson, FM
    Kayes, KM
    Agarwal, AK
    STEROIDS, 1997, 62 (01) : 83 - 88
  • [38] Molecular studies of 11 beta-hydroxysteroid dehydrogenase in human granulosa cells
    Smith, MP
    Keay, SD
    Hall, L
    Harlow, CR
    Jenkins, JM
    HUMAN REPRODUCTION, 1997, 12 (05) : S16 - S16
  • [39] 11β-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor in human fetal development
    Hirasawa, G
    Sasano, H
    Suzuki, T
    Takeyama, T
    Muramatu, Y
    Fukushima, K
    Hiwatashi, N
    Toyota, T
    Nagura, H
    Krozowski, ZS
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (04): : 1453 - 1458
  • [40] Cytochrome P450-7B1 and 11 beta-hydroxysteroid dehydrogenase type 1 distribution in human tissues
    Chalbot, Sonia
    Morfin, Robert
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2012, 9 (03) : 179 - 189